Exploring how music affects brain development in preterm infants
The Effect of Music on Functional Processing and Structural and Functional Development of the Preterm Infant's Brain
This study tests whether listening to music can help the brain development of preterm infants born between 33 and 37 weeks, compared to full-term newborns.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 63 (estimated) |
| Ages | 33 Weeks to 42 Weeks |
| Sex | All |
| Sponsor | Pediatric Clinical Research Platform Academic / other |
| Locations | 1 site (Geneva) |
| Trial ID | NCT03689725 on ClinicalTrials.gov |
What this trial studies
This study investigates the impact of music intervention on the brain development of preterm infants through MRI scans and neurodevelopmental assessments. It focuses on infants born between 33 and 37 weeks of gestational age, as well as full-term newborns. The research aims to determine whether exposure to music can positively influence neurological outcomes in these vulnerable populations. By comparing brain development metrics, the study seeks to provide insights into the potential benefits of music therapy for preterm infants.
Who should consider this trial
Good fit: Ideal candidates for this study are preterm infants born between 33 and 37 weeks of gestational age and full-term newborns aged 37 to 42 weeks.
Not a fit: Patients with neurological issues or malformations, as well as those requiring continuous positive airway pressure without a pause, may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could enhance brain development in preterm infants, potentially leading to improved long-term neurological outcomes.
How similar studies have performed: While the specific approach of using music for brain development in preterm infants is relatively novel, there have been other studies exploring music therapy's benefits in various populations, suggesting potential for success.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Preterm infants: 33 weeks \< gestational age \< 37 weeks * Full-term newborns: 37 weeks gestational age \< 42 weeks Exclusion Criteria: * Neurological issues or malformations (such as III-IV stade Intraventricular hemorrhage, micro or macrocephaly, hydrocephaly...) * Because of the high noise caused by nasal continuous positive airway pressure (nCPAP), preterm newborns without at least nCPAP pause before 32 6/7 gestational age will be excluded
Where this trial is running
Geneva
- Prof. Petra S. Hüppi — Geneva, Switzerland (Recruiting)
Study contacts
- Study coordinator: Petra S. Hüppi, Prof.
- Email: petra.huppi@hcuge.ch
- Phone: 0223824352
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.